LNAI
Income statement / Annual
Last year (2025), Lunai Bioworks Inc.'s total revenue was $51.99 K,
and the percentage change from the previous year is not available.
In 2025, Lunai Bioworks Inc.'s net income was -$3.56 M.
See Lunai Bioworks Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2025
|
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
| Period Ended |
06/30/2026 |
06/30/2025 |
06/30/2024 |
06/30/2023 |
06/30/2022 |
06/30/2021 |
| Operating Revenue |
$51.99 K |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Cost of Revenue |
$93.52 K
|
$129.09 K
|
$0.00
|
$0.00
|
$0.00
|
$391.42 K
|
| Gross Profit |
-$41.53 K
|
-$129.09 K
|
$0.00
|
$0.00
|
$0.00
|
-$391.42 K
|
| Gross Profit Ratio |
-0.8
|
0
|
0
|
0
|
0
|
0
|
| Research and Development Expenses |
$24.52 M
|
$537.43 K
|
$2.71 M
|
$4.17 M
|
$8.37 M
|
$15.54 M
|
| General & Administrative Expenses |
$7.80 B
|
$17.88 M
|
$24.56 M
|
$15.32 M
|
$14.33 M
|
$0.00
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$7.80 B
|
$17.88 M
|
$24.56 M
|
$15.32 M
|
$14.33 M
|
$7.47 M
|
| Other Expenses |
-$7.82 B
|
$0.00
|
$54.37 M
|
$19.07 M
|
$93.38 M
|
$0.00
|
| Operating Expenses |
$7.82 M
|
$18.42 M
|
$81.64 M
|
$38.56 M
|
$116.08 M
|
$23.01 M
|
| Cost And Expenses |
$7.92 M
|
$18.55 M
|
$81.64 M
|
$38.56 M
|
$116.08 M
|
$23.40 M
|
| Interest Income |
$0.00
|
$116.35 K
|
$0.00
|
$0.00
|
$122.04 K
|
$13.18 K
|
| Interest Expense |
$235.07 K
|
$725.68 K
|
$2.43 M
|
$706.96 K
|
$372.84 K
|
$379.61 K
|
| Depreciation & Amortization |
$93.52 K
|
$129.10 K
|
$121.86 K
|
$113.50 K
|
$123.59 K
|
$391.42 K
|
| EBITDA |
-$7.77 M |
-$177.15 M |
-$85.87 M |
-$38.86 M |
-$112.94 M |
-$26.08 M |
| EBITDA Ratio |
-149.49
|
0
|
0
|
0
|
0
|
0
|
| Operating Income Ratio |
-151.29
|
0
|
0
|
0
|
0
|
0
|
| Total Other Income/Expenses Net |
$4.30 M
|
-$159.46 M
|
-$6.79 M
|
-$1.13 M
|
$2.65 M
|
-$3.45 M
|
| Income Before Tax |
-$3.56 M
|
-$178.01 M
|
-$88.43 M
|
-$39.68 M
|
-$113.43 M
|
-$26.85 M
|
| Income Before Tax Ratio |
-68.52
|
0
|
0
|
0
|
0
|
0
|
| Income Tax Expense |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$34.00
|
-$125.28 K
|
| Net Income |
-$3.56 M
|
-$178.01 M
|
-$88.43 M
|
-$39.68 M
|
-$113.43 M
|
-$26.72 M
|
| Net Income Ratio |
-68.52
|
0
|
0
|
0
|
0
|
0
|
| EPS |
-1.06 |
-86.24 |
-72.8 |
-56.8 |
-172.8 |
-45.36 |
| EPS Diluted |
-1.06 |
-86.24 |
-72.8 |
-56.8 |
-172.8 |
-45.36 |
| Weighted Average Shares Out |
$3.36 M
|
$2.06 M
|
$1.22 M
|
$703.32 K
|
$656.60 K
|
$589.59 K
|
| Weighted Average Shares Out Diluted |
$3.36 M
|
$2.06 M
|
$1.22 M
|
$703.32 K
|
$656.60 K
|
$589.59 K
|
| Link |
|
|
|
|
|
|
